- Home
- LFVN vs TERN Comparison
LFVN vs TERN Comparison
Compare LFVN & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- TERN
- Stock Information
- Founded
- LFVN N/A
- TERN 2017
- Country
- LFVN United States
- TERN United States
- Employees
- LFVN N/A
- TERN N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- LFVN Health Care
- TERN Health Care
- Exchange
- LFVN Nasdaq
- TERN Nasdaq
- Market Cap
- LFVN 269.4M
- TERN 298.1M
- IPO Year
- LFVN N/A
- TERN 2021
- Fundamental
- Price
- LFVN $14.58
- TERN $2.76
- Analyst Decision
- LFVN Strong Buy
- TERN Buy
- Analyst Count
- LFVN 2
- TERN 6
- Target Price
- LFVN $30.50
- TERN $18.30
- AVG Volume (30 Days)
- LFVN 172.7K
- TERN 917.8K
- Earning Date
- LFVN 05-01-2025
- TERN 03-20-2025
- Dividend Yield
- LFVN 1.09%
- TERN N/A
- EPS Growth
- LFVN 139.37
- TERN N/A
- EPS
- LFVN 0.56
- TERN N/A
- Revenue
- LFVN $212,152,000.00
- TERN N/A
- Revenue This Year
- LFVN $22.17
- TERN N/A
- Revenue Next Year
- LFVN $8.73
- TERN N/A
- P/E Ratio
- LFVN $25.62
- TERN N/A
- Revenue Growth
- LFVN 0.57
- TERN N/A
- 52 Week Low
- LFVN $5.22
- TERN $2.75
- 52 Week High
- LFVN $27.38
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- LFVN 35.17
- TERN 30.05
- Support Level
- LFVN $14.28
- TERN $3.07
- Resistance Level
- LFVN $15.28
- TERN $3.72
- Average True Range (ATR)
- LFVN 0.94
- TERN 0.22
- MACD
- LFVN -0.05
- TERN -0.01
- Stochastic Oscillator
- LFVN 13.92
- TERN 1.03
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.